Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 110

References for PMC Articles for PubMed (Select 20708548)

1.

Diagnostic value of proton magnetic resonance spectroscopy in the noninvasive grading of solid gliomas: comparison of maximum and mean choline values.

Senft C, Hattingen E, Pilatus U, Franz K, Schänzer A, Lanfermann H, Seifert V, Gasser T.

Neurosurgery. 2009 Nov;65(5):908-13; discussion 913. doi: 10.1227/01.NEU.0000356982.82378.BA.

PMID:
19834403
2.

New advances that enable identification of glioblastoma recurrence.

Yang I, Aghi MK.

Nat Rev Clin Oncol. 2009 Nov;6(11):648-57. doi: 10.1038/nrclinonc.2009.150. Epub 2009 Oct 6. Review.

PMID:
19806145
3.

Pattern recognition of MRSI data shows regions of glioma growth that agree with DTI markers of brain tumor infiltration.

Wright AJ, Fellows G, Byrnes TJ, Opstad KS, McIntyre DJ, Griffiths JR, Bell BA, Clark CA, Barrick TR, Howe FA.

Magn Reson Med. 2009 Dec;62(6):1646-51. doi: 10.1002/mrm.22163.

PMID:
19785020
4.

MR spectroscopy in radiation injury.

Sundgren PC.

AJNR Am J Neuroradiol. 2009 Sep;30(8):1469-76. doi: 10.3174/ajnr.A1580. Epub 2009 Apr 15. Review.

5.

Integration of preoperative anatomic and metabolic physiologic imaging of newly diagnosed glioma.

Chang SM, Nelson S, Vandenberg S, Cha S, Prados M, Butowski N, McDermott M, Parsa AT, Aghi M, Clarke J, Berger M.

J Neurooncol. 2009 May;92(3):401-15. doi: 10.1007/s11060-009-9845-0. Epub 2009 Apr 9.

6.

Neuroimaging.

Klingebiel R, Bohner G.

Recent Results Cancer Res. 2009;171:175-90. doi: 10.1007/978-3-540-31206-2_11. Review.

PMID:
19322545
7.

Adjuvant therapy.

Wick W, Weller M.

Recent Results Cancer Res. 2009;171:141-53. doi: 10.1007/978-3-540-31206-2_8. Review.

PMID:
19322542
8.

Radiation therapy.

Combs SE.

Recent Results Cancer Res. 2009;171:125-40. doi: 10.1007/978-3-540-31206-2_7. Review.

PMID:
19322541
9.

Metabolic alterations: a biomarker for radiation-induced normal brain injury-an MR spectroscopy study.

Sundgren PC, Nagesh V, Elias A, Tsien C, Junck L, Gomez Hassan DM, Lawrence TS, Chenevert TL, Rogers L, McKeever P, Cao Y.

J Magn Reson Imaging. 2009 Feb;29(2):291-7. doi: 10.1002/jmri.21657.

10.

Developing a clinical decision model: MR spectroscopy to differentiate between recurrent tumor and radiation change in patients with new contrast-enhancing lesions.

Smith EA, Carlos RC, Junck LR, Tsien CI, Elias A, Sundgren PC.

AJR Am J Roentgenol. 2009 Feb;192(2):W45-52. doi: 10.2214/AJR.07.3934.

PMID:
19155380
11.

Proton MR spectroscopy improves discrimination between tumor and pseudotumoral lesion in solid brain masses.

Majós C, Aguilera C, Alonso J, Julià-Sapé M, Castañer S, Sánchez JJ, Samitier A, León A, Rovira A, Arús C.

AJNR Am J Neuroradiol. 2009 Mar;30(3):544-51. doi: 10.3174/ajnr.A1392. Epub 2008 Dec 18.

12.

Relationship of pre-surgery metabolic and physiological MR imaging parameters to survival for patients with untreated GBM.

Crawford FW, Khayal IS, McGue C, Saraswathy S, Pirzkall A, Cha S, Lamborn KR, Chang SM, Berger MS, Nelson SJ.

J Neurooncol. 2009 Feb;91(3):337-51. doi: 10.1007/s11060-008-9719-x. Epub 2008 Nov 15.

13.

MRI for identification of progression in brain tumors: from morphology to function.

Weber MA, Giesel FL, Stieltjes B.

Expert Rev Neurother. 2008 Oct;8(10):1507-25. doi: 10.1586/14737175.8.10.1507. Review.

PMID:
18928344
14.

Evaluation of MR markers that predict survival in patients with newly diagnosed GBM prior to adjuvant therapy.

Saraswathy S, Crawford FW, Lamborn KR, Pirzkall A, Chang S, Cha S, Nelson SJ.

J Neurooncol. 2009 Jan;91(1):69-81. doi: 10.1007/s11060-008-9685-3. Epub 2008 Sep 23.

15.

Stereotactic biopsy in gliomas guided by 3-tesla 1H-chemical-shift imaging of choline.

Hermann EJ, Hattingen E, Krauss JK, Marquardt G, Pilatus U, Franz K, Setzer M, Gasser T, Tews DS, Zanella FE, Seifert V, Lanfermann H.

Stereotact Funct Neurosurg. 2008;86(5):300-7. doi: 10.1159/000155232. Epub 2008 Sep 15.

PMID:
18791331
16.

Prognostic value of choline and creatine in WHO grade II gliomas.

Hattingen E, Raab P, Franz K, Lanfermann H, Setzer M, Gerlach R, Zanella FE, Pilatus U.

Neuroradiology. 2008 Sep;50(9):759-67. doi: 10.1007/s00234-008-0409-3. Epub 2008 Jun 4.

PMID:
18523762
17.
18.

Mimicking the human expert: pattern recognition for an automated assessment of data quality in MR spectroscopic images.

Menze BH, Kelm BM, Weber MA, Bachert P, Hamprecht FA.

Magn Reson Med. 2008 Jun;59(6):1457-66. doi: 10.1002/mrm.21519.

PMID:
18421692
19.

Proton MR spectroscopy of cerebral gliomas at 3 T: spatial heterogeneity, and tumour grade and extent.

Di Costanzo A, Scarabino T, Trojsi F, Popolizio T, Catapano D, Giannatempo GM, Bonavita S, Portaluri M, Tosetti M, d'Angelo VA, Salvolini U, Tedeschi G.

Eur Radiol. 2008 Aug;18(8):1727-35. doi: 10.1007/s00330-008-0938-5. Epub 2008 Apr 4.

PMID:
18389246
20.

Proton magnetic resonance spectroscopic imaging in newly diagnosed glioblastoma: predictive value for the site of postradiotherapy relapse in a prospective longitudinal study.

Laprie A, Catalaa I, Cassol E, McKnight TR, Berchery D, Marre D, Bachaud JM, Berry I, Moyal EC.

Int J Radiat Oncol Biol Phys. 2008 Mar 1;70(3):773-81. doi: 10.1016/j.ijrobp.2007.10.039.

PMID:
18262090
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk